Previous studies have suggested that profound inhibition of gastric acid secretion may increase exposure to potentially carcinogenic N-nitroso compounds. The 42 (19-194) 
tmol/l). There was also no increase in the concentrations of nitrates or nitrites. It is concluded that omeprazole (20 mg once daily) for two weeks in healthy volunteers is associated with gastric bacterial proliferation but does not increase concentrations of N-nitroso compounds.
(Gut 1994; 35: [455] [456] [457] [458] [459] [460] Omeprazole has been established as an effective treatment for peptic ulceration and reflux oesophagitis, for periods of up to five years.' 5 There are still concerns regarding the possible risks of prolonged gastric acid suppression.6-9 Prominent among these are uncertainties of adverse effects consequent on bacterial proliferation and colonisation of the upper gastrointestinal tract.
Decreased gastric acidity because of age,'0 antacids,"'-" H2 receptor antagonists, 'I"45 and gastric surgery'6 has previously been reported to increase gastric bacterial colonisation and this has been proposed to increase the formation of potentially carcinogenic N-nitroso compounds. '7-20 A single study has reported that in healthy subjects, 14 days' treatment with 30 mg omeprazole once daily leads to an increase in the number of bacteria present in the stomach including nitrate reducing bacteria.'9 As gastric volumes were not assessed, however, it has been suggested that this may have represented an increase in bacterial concentration attributable to a decrease in gastric secretion and, hence, overall gastric volume rather than a true increase in bacterial load -that is, the total number of bacteria.2' In addition, samples of gastric juice were obtained through a nasogastric tube that had remained in situ for 10 hours, with the attendant problems of possible contamination. Furthermore, the method used to assess Nnitroso compounds in this study has been shown to be inadequate for the determination oftotal Nnitroso compounds. 2223 We have therefore assessed the influence of 14 days' treatment of omeprazole, 20 mg daily, on total gastric bacteria as well as nitrate reducing bacterial counts by gastric juice aspiration, and measured residual gastric volumes to determine the total number of these organisms in the stomach. To avoid the problems inherent in obtaining bacteriological samples with a nasogastric tube, a novel sampling technique was used to obtain uncontaminated gastric samples. 24 Finally, both the concentration and total gastric content of N-nitroso compounds (NOC) and their precursors, nitrates and nitrites were measured using a modified extraction procedure to maximise the retrieval of N-nitroso compounds.
Subjects and methods

SUBJECTS
Studies were performed in 14 Nitrate, nitrite, and NOC assays For the nitrate and nitrite assays, 0-6 ml of gastric juice was added to a tube containing 0-2 ml of NaOH 0 5 N. The NOC assays were performed on a further 2-5 ml of gastric juice, which was placed in a Pyrex/Teflon joint stoppered vial containing 50 mg of solid sulphamic acid, kept at room temperature with protection from light for a further four minutes and then stored in the dark at -20°C until analysis within eight days. Nitrite was determined colorimetrically by diazotisation of sulphanilic acid followed by coupling to N-(l-napthyl)-ethylenediamine after removal of interfering substances on an anion exchange column. Nitrate was analysed by the same method after reduction to nitrite on a cadmium column.27 NOC concentrations were determined using a previously described technique. 11 Briefly the gastric juice sample was injected directly into refluxing ethyl acetate, containing either acetic acid -0-1% (vol/vol) HC1 for determining thermo and acetic acid labile thermal energy analyser responsive compounds (TAC) or hydrogen bromide for the determination of TAC plus NOC. The amount ofnitric oxide released in each case was measured through chemoluminescence detection using a thermal energy analyser, with the difference between the two determinations representing the concentration of total NOC in the sample. The limit of detection was 0-01 ,tmol/l. pH measurements Immediately after aspiration, the pH of aspirates was determined using a combined glass electrode (M3-440, Ingold Messtechnik AG, Urdorf, Switzerland) and a precalibrated pH meter (Radiometer pHM 75, Radiometer, Copenhagen, Denmark).
Residual gastric volume After aspiration of the gastric samples for determination of bacterial counts, and concentrations of nitrate, nitrite, and NOC, 50 ml of polyethylene glycol solution 4000 (PEG) was instilled through the nasogastric tube; the subject then moved around on the examination couch over a five minute period to permit thorough mixing of gastric contents. The stomach was then aspirated to dryness; the volume of aspirate was noted and two 1 ml aliquots were stored at -20°C for subsequent measurement of PEG concentration by turbidimetry28 to permit evaluation of the residual gastric volume before insertion of nasogastric tube.
Evaluation ofresults and statistical analysis Statistical evaluation of paired data was performed using the Wilcoxon's signed rank test. 29 The Spearman rank correlation coefficient test was used to test the relation between pH values and bacterial counts, and concentrations ofNOC and nitrite. The difference between bacterial counts, nitrites, and NOC at pH values above and below 4 were compared with the MannWhitney U test.
Bacterial, nitrate, nitrite, and NOC contents were calculated by multiplying and concentrations by the calculated residual gastric volume. All data are presented as medians (range).
Results
Fourteen subjects completed the study. One subject withdrew from the study after the first week for reasons unconnected with the experiment and was replaced according to protocol. Epigastric pain was reported by one subject two days after starting omeprazole and diarrhoea was reported by another during treatment with placebo. Both subjects completed the study and no other adverse events were noted. 
Gastric volume
The median fasting gastric volume was 41-5 ml (19-193 7) during placebo treatment. There were no significant changes in the median gastric volumes after either one or two weeks of omeprazole treatment: 41-5 ml (21 9-137-7) and 64-9 ml (28 6-154-9) respectively. BACTERIOLOGY Table I lists the bacterial species found in gastric juice during treatment with placebo and after omeprazole. There was a significant increase in the total bacterial concentration after one (p<005) and two weeks (p<005) of omeprazole without a significant difference between the first and second treatment week of omeprazole (Fig 1) . The total number of bacteria in gastric juice also increased significantly after one and two weeks of omeprazole (p<005 v placebo), but there was no significant difference between the first and second week of omeprazole (Fig 2) .
There was a significant increase in the concentration of nitrate reducing bacteria after one and two weeks of omeprazole (p<005 v placebo) without a significant difference between the first and second week ofomeprazole (Fig 1) . The total number of nitrate reducing bacteria in gastric juice also increased after one and two weeks of omeprazole (p<005 v placebo) without a (Fig 3) . Total nitrite content did not change after one and two weeks' treatment with omeprazole when compared with placebo (Fig 4) .
N-nitroso compounds (NOC)
There was no significant difference in the concentrations of NOC after one and two weeks' treatment with omeprazole compared with placebo (Fig 3) . There was also no significant difference in the total NOC contents after one and two weeks' treatment with omeprazole compared with placebo (Fig 4) .
RELATION BETWEEN pH, BACTERIAL COUNTS, NITRATES, NITRITES, AND N-NITROSO COMPOUNDS
Total bacterial concentrations and nitrate reducing bacteria concentrations were significantly higher when aspirate pH was >4 (Table II Values are shown as medians and range at pH less than and greater than 4. The nitrite and NOC concentrations when the aspirate was >4 pH were not significantly different from those when pH was <4 despite a significant increase in both total bacteria and nitrate reducing bacteria when aspirate pH was >4 (p<0-001 This study also showed that reduced acid secretion after omeprazole is associated with proliferation ofbacteria, including nitrate reducing species but it has not confirmed a subsequent increase in nitrite or NOC production for the group as a whole. The most notable difference between the two studies is that the median bacterial counts reported by Sharma et al were more than 100-fold greater than those seen in this study. As omeprazole produces a dose dependent increase in gastric pH,4' the lower bacterial counts in this study could have been a result of differences in intragastric pH because of the lower dose of omeprazole in the study (20 
